18 filings
6-K
ENTX
Entera Bio Ltd
18 Dec 19
Entera Bio Announces the Completion of $14.3 million Private Placement
4:30pm
6-K
ENTX
Entera Bio Ltd
11 Dec 19
Entera Announces Closing of Private Placement
5:02pm
6-K
ENTX
Entera Bio Ltd
21 Nov 19
Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial Officer
7:01am
6-K
ENTX
Entera Bio Ltd
21 Nov 19
Condensed Consolidated Interim Financial Statements
7:00am
6-K
ENTX
Entera Bio Ltd
10 Oct 19
Current report (foreign)
4:05pm
6-K
xtnu91tn8i m8m0
23 Sep 19
Current report (foreign)
8:00am
6-K
dx5nchm8a6q
29 Aug 19
Current report (foreign)
8:00am
6-K
b7zktc9
20 Aug 19
Condensed Consolidated Interim Financial Statements
7:16am
6-K
tu3b1cet
5 Aug 19
Entera Bio Appoints Adam Gridley as Chief Executive Officer
8:00am
6-K
wv3tv92269ytzwu7z
2 Jul 19
Entera Announces Initiation of Phase 2 Dose Ranging Study for Oral PTH
7:05am
6-K
255wkyovpwi2dgna2iw
27 Jun 19
Condensed Consolidated Interim Financial Statements
7:14am
6-K
ashkp1c
23 May 19
Current report (foreign)
9:39am
6-K
hwuwv0mhkewk
15 Apr 19
Current report (foreign)
8:33am
6-K
0ug25kkb6m 1o42oju
28 Mar 19
Current report (foreign)
7:05am
6-K
wnt60qqwrqez
7 Mar 19
Current report (foreign)
7:03am
6-K
ubqr r7w8i130pz
31 Jan 19
Current report (foreign)
8:04am
6-K
n66f 35dq62
22 Jan 19
Condensed Consolidated Interim Financial Statements
8:07am
6-K
o1cm0
10 Jan 19
Entera Bio Appoints Gerald M. Ostrov to Board of Directors
7:04am
- Prev
- 1
- Next